Study title: [Chloramphenicol eyedrops in acute bacterial conjunctivitis. A comparison of 2 dosage regimes in general practice] Laerum E, Fiskaadal HJ, Erdal JE, Løberg RM. Tidsskr Nor Laegeforen. 1994 Feb 28;114(6):671-3. [Chloramphenicol eyedrops in acute bacterial conjunctivitis. A comparison of 2 dosage regimes in general practice] Laerum E, Fiskaadal HJ, Erdal JE, Løberg RM. Tidsskr Nor Laegeforen. 1994 Feb 28;114(6):671-3.
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Eye Diseases | |||||
| Brands: Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: CHLORAMPHENICOL_ CHLORAMPHENICOL +CORTISONE ACETATE +ETHACRIDINE LACTATE +ZINC OXIDE / CHLORAMPHENICOL AND MEDROXYPROGESTERONE AND TETRYZOLINE | |||||
| ATC code: S01AA01 | |||||
| Document link: Chloramphenicol eyedrops in acute bacterial conjunctivitis (.pdf | |||||
| Document date: 2011-11-09 | |||||
| Study number: | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | Y | - | |